ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Tetrahydrofuran → methyl {3-[2-({(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-1,3-oxazolidin-3-yl}methyl)-6-chloropyridin-3-yl]-4-methoxyphenyl}acetate

HRID 604672
印刷

反応式

HRID 604672 の反応式
[F:1][C:2]([F:30])([F:29])[C:3]1[CH:4]=[C:5]([C@H:13]2[O:17][C:16](=[O:18])[N:15]([CH2:19][C:20]3[C:25](Br)=[CH:24][CH:23]=[C:22]([Cl:27])[N:21]=3)[C@H:14]2[CH3:28])[CH:6]=[C:7]([C:9]([F:12])([F:11])[F:10])[CH:8]=1.[CH3:31][O:32][C:33]1[CH:38]=[CH:37][C:36]([CH2:39][C:40]([O:42][CH3:43])=[O:41])=[CH:35][C:34]=1B1OC(C)(C)C(C)(C)O1.C([O-])([O-])=O.[K+].[K+].C1COCC1>CCOC(C)=O.[Pd](Cl)Cl.C(P(C(C)(C)C)[C-]1C=CC=C1)(C)(C)C.[C-]1(P(C(C)(C)C)C(C)(C)C)C=CC=C1.[Fe+2]>[F:1][C:2]([F:30])([F:29])[C:3]1[CH:4]=[C:5]([C@H:13]2[O:17][C:16](=[O:18])[N:15]([CH2:19][C:20]3[C:25]([C:38]4[CH:37]=[C:36]([CH2:39][C:40]([O:42][CH3:43])=[O:41])[CH:35]=[CH:34][C:33]=4[O:32][CH3:31])=[CH:24][CH:23]=[C:22]([Cl:27])[N:21]=3)[C@H:14]2[CH3:28])[CH:6]=[C:7]([C:9]([F:12])([F:11])[F:10])[CH:8]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 8028TetrahydrofuranHCID 11430Potassium CarbonateHCID 57576268(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[(3-bromo-6-chloropyridin-2-yl)methyl]-4-methyl-1,3-oxazolidin-2-oneHCID 57576289Methyl 2-(4-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-YL)phenyl)acetate

生成物 1

HCID 57576209
methyl {3-[2-({(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-1,3-oxazolidin-3-yl}methyl)-6-chloropyridin-3-yl]-4-methoxyphenyl}acetate

試薬・触媒・溶媒 2

HCID 178454861HCID 178454861、化合物触媒HCID 8857Ethyl Acetate溶媒

実験手順

A flask was charged with (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[(3-bromo-6-chloropyridin-2-yl)methyl]-4-methyl-1,3-oxazolidin-2-one (265 mg, 0.511 mmol), methyl [4-methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetate (156.6 mg, 0.511 mmol), 1M K2CO3 (4 mL, 4 mmol), and THF (4 mL). The reaction was degassed with N2 and then 1,1′-bis(di-t-butylphosphino)ferrocene palladium dichloride (16.7 mg, 0.026 mmol) was added while the reaction was stirred vigorously. Vigorous stirring was continued for 15 min at room temperature, and then the reaction was diluted with EtOAc (40 mL) and washed with water and brine (20 mL each). The organic layer was dried (Na2SO4), filtered, and concentrated. The residue was purified by flash chromatography on silica gel (0 to 70% EtOAc/hexanes) to afford methyl {3-[2-({(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-2-oxo-1,3-oxazolidin-3-yl}methyl)-6-chloropyridin-3-yl]-4-methoxyphenyl}acetate. Rf=0.21 (25% EtOAc/hexanes). LCMS=617.4 (M+H)+. 1H NMR (500 MHz, CDCl3): δ 6.92-7.83 (m, 8H), 4.88-5.68 (m, 2H), 3.58-4.19 (m, 10H), 0.63 (s, 3H).

後処理

  1. customThe reaction was degassed with N2
  2. stirringVigorous stirring
  3. washwashed with water and brine (20 mL each)
  4. dry with materialThe organic layer was dried (Na2SO4)
  5. filtrationfiltered
  6. concentrationconcentrated
  7. customThe residue was purified by flash chromatography on silica gel (0 to 70% EtOAc/hexanes)

出典と根拠

ORDレコード
ord-a24322568b8e42fd9c2393683487e582
出典データセット
uspto-grants-2011_03
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07910592B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート